Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients
Status:
Completed
Trial end date:
2016-11-25
Target enrollment:
Participant gender:
Summary
To assess whether the inhalative combination of Tobramycin/Colistin is more effective in
reducing Pseudomonas colony forming units (CFUs) and improvement of lung function than
Colistin in mono-therapy.